Literature DB >> 22155509

Molecular characterisation of the Hyp deletion and an improved assay for its detection.

Campbell R Sheen1, Genay O W Pilarowski, Wei Wang, Jose Luis Millan.   

Abstract

The Hyp mouse is a commonly used model for the study of the phosphate wasting disease X-linked hypophosphataemia. The defect in this mouse line is a deletion that includes exons 16 to 22 of Phex, although the exact extent of this X chromosome deletion remains unknown. This complicates genotyping which increases costs, time and difficulty of working with this important model. We aimed to determine the molecular breakpoints of this deletion in order develop a robust assay for its detection. We designed short mapping PCRs around the Phex locus to refine the putative breakpoint locations, then used gap PCR to amplify a product containing the breakpoint junction. DNA sequencing showed the deleted region was approximately 297 kb, significantly larger than previous reports, but did not contain any genes other than Phex. DNA sequence analysis revealed that this deletion may be the result of microhomology-mediated end joining. Finally, we designed a multiplex PCR assay for genotyping Hyp colonies and validated it using a panel of Hyp colony mice. This study provides confirmation of the Hyp phenotype as a single gene defect, a potential mechanism for its formation and an improved method for genotyping that will make working with this strain significantly easier. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22155509      PMCID: PMC3278584          DOI: 10.1016/j.bone.2011.11.018

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  10 in total

Review 1.  MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings.

Authors:  Mitch McVey; Sang Eun Lee
Journal:  Trends Genet       Date:  2008-09-21       Impact factor: 11.639

Review 2.  FGF23 and disorders of phosphate homeostasis.

Authors:  Xijie Yu; Kenneth E White
Journal:  Cytokine Growth Factor Rev       Date:  2005-02-05       Impact factor: 7.638

3.  Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia.

Authors:  T M Strom; F Francis; B Lorenz; A Böddrich; M J Econs; H Lehrach; T Meitinger
Journal:  Hum Mol Genet       Date:  1997-02       Impact factor: 6.150

4.  Pathogenic role of Fgf23 in Hyp mice.

Authors:  Shiguang Liu; Jianping Zhou; Wen Tang; Xi Jiang; David W Rowe; L Darryl Quarles
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01-31       Impact factor: 4.310

5.  Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice.

Authors:  L Beck; Y Soumounou; J Martel; G Krishnamurthy; C Gauthier; C G Goodyer; H S Tenenhouse
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 6.  Regulation of DNA double-strand break repair pathway choice.

Authors:  Meena Shrivastav; Leyma P De Haro; Jac A Nickoloff
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

7.  A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium.

Authors: 
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

8.  Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets.

Authors:  E M Eicher; J L Southard; C R Scriver; F H Glorieux
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

9.  The X chromosome deletion in HYP mice extends into the intergenic region but does not include the SAT gene downstream from Phex.

Authors:  Y Sabbagh; C Gauthier; H S Tenenhouse
Journal:  Cytogenet Genome Res       Date:  2002       Impact factor: 1.636

10.  Annotation, submission and screening of repetitive elements in Repbase: RepbaseSubmitter and Censor.

Authors:  Oleksiy Kohany; Andrew J Gentles; Lukasz Hankus; Jerzy Jurka
Journal:  BMC Bioinformatics       Date:  2006-10-25       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.